A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111
Clinical trial NCT03507686 · COMPLETED
Trial details
- NCT number
- NCT03507686
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2022-06-29
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.